{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:25:53Z","timestamp":1793107553584,"version":"4.5.0"},"reference-count":264,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Neuroinflammatory and neurodegenerative disorders including Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), traumatic brain injury (TBI) and Amyotrophic lateral sclerosis (ALS) are chronic major health disorders. The exact mechanism of the neuroimmune dysfunctions of these disease pathogeneses is currently not clearly understood. These disorders show dysregulated neuroimmune and inflammatory responses, including activation of neurons, glial cells, and neurovascular unit damage associated with excessive release of proinflammatory cytokines, chemokines, neurotoxic mediators, and infiltration of peripheral immune cells into the brain, as well as entry of inflammatory mediators through damaged neurovascular endothelial cells, blood\u2013brain barrier and tight junction proteins. Activation of glial cells and immune cells leads to the release of many inflammatory and neurotoxic molecules that cause neuroinflammation and neurodegeneration. Gulf War Illness (GWI) and myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) are chronic disorders that are also associated with neuroimmune dysfunctions. Currently, there are no effective disease-modifying therapeutic options available for these diseases. Human induced pluripotent stem cell (iPSC)-derived neurons, astrocytes, microglia, endothelial cells and pericytes are currently used for many disease models for drug discovery. This review highlights certain recent trends in neuroinflammatory responses and iPSC-derived brain cell applications in neuroinflammatory disorders.<\/jats:p>","DOI":"10.3390\/cells13060511","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T12:02:39Z","timestamp":1710504159000},"page":"511","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders"],"prefix":"10.3390","volume":"13","author":[{"given":"Jessica","family":"Cohen","sequence":"first","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Mathew","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk D.","family":"Dourvetakis","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estella","family":"Sanchez-Guerrero","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra P.","family":"Pangeni","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-1354","authenticated-orcid":false,"given":"Narasimman","family":"Gurusamy","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina K.","family":"Aenlle","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"},{"name":"Miami VA Geriatric Research Education and Clinical Center (GRECC), Miami Veterans Affairs Healthcare System, Miami, FL 33125, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Ravindran","sequence":"additional","affiliation":[{"name":"Cell Therapy Institute, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assma","family":"Twahir","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Isler","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Rukmini","family":"Sosa-Garcia","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Llizo","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison C.","family":"Bested","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-460X","authenticated-orcid":false,"given":"Theoharis C.","family":"Theoharides","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"},{"name":"Laboratory of Molecular Immunopharmacology and Drug Discovery, Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy G.","family":"Klimas","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"},{"name":"Miami VA Geriatric Research Education and Clinical Center (GRECC), Miami Veterans Affairs Healthcare System, Miami, FL 33125, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1148-8681","authenticated-orcid":false,"given":"Duraisamy","family":"Kempuraj","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lamptey, R.N.L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., and Singh, J. (2022). A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031851"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11011-021-00800-w","article-title":"Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment","volume":"37","author":"Pathak","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"ref_3","first-page":"153951","article-title":"Neuroinflammation disorders exacerbated by environmental stressors","volume":"100S","author":"Miller","year":"2019","journal-title":"Metabolism"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F.T., and Arab-Tehrany, E. (2022). Alzheimer\u2019s Disease: Treatment Strategies and Their Limitations. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213954"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-019-02009-9","article-title":"Neuroinflammation, the thread connecting neurological disease: Cluster: \u201cNeuroinflammatory mechanisms in neurodegenerative disorders\u201d","volume":"137","author":"Brambilla","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"827263","DOI":"10.3389\/fnagi.2022.827263","article-title":"Neuroinflammation: A Possible Link between Chronic Vascular Disorders and Neurodegenerative Diseases","volume":"14","author":"Moyse","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","article-title":"Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease","volume":"29","author":"Dhapola","year":"2021","journal-title":"Inflammopharmacology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","article-title":"Microglia in the Neuroinflammatory Pathogenesis of Alzheimer\u2019s Disease and Related Therapeutic Targets","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8098439","DOI":"10.1155\/2020\/8098439","article-title":"The Mast Cell Is an Early Activator of Lipopolysaccharide-Induced Neuroinflammation and Blood-Brain Barrier Dysfunction in the Hippocampus","volume":"2020","author":"Wang","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer\u2019s Disease: Current Progress in Molecular Signaling and Therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-immunol-042718-041812","article-title":"Neuro-Immune Cell Units: A New Paradigm in Physiology","volume":"37","author":"Cardoso","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"739130","DOI":"10.3389\/fimmu.2021.739130","article-title":"PET Imaging of Neuroinflammation in Alzheimer\u2019s Disease","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fncel.2017.00216","article-title":"Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration","volume":"11","author":"Kempuraj","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Theoharides, T.C., Twahir, A., and Kempuraj, D. (2023). Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation. Ann. Allergy Asthma Immunol., S1081-1206(23)01397-2.","DOI":"10.1016\/j.anai.2023.10.032"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101802","DOI":"10.1016\/j.smim.2023.101802","article-title":"The gut-brain vascular axis in neuroinflammation","volume":"69","author":"Carloni","year":"2023","journal-title":"Semin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-0716-3287-1_7","article-title":"Modeling Cellular Crosstalk of Neuroinflammation Axis by Tri-cultures of iPSC-Derived Human Microglia, Astrocytes, and Neurons","volume":"2683","author":"Connolly","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-0716-2655-9_7","article-title":"Modeling Alzheimer\u2019s Disease Using Human Brain Organoids","volume":"2561","author":"Karmirian","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s12015-021-10254-3","article-title":"Human iPSC-Derived Neural Models for Studying Alzheimer\u2019s Disease: From Neural Stem Cells to Cerebral Organoids","volume":"18","author":"Barak","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jconrel.2020.11.021","article-title":"Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics","volume":"330","author":"Akhtar","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Achar, A., Myers, R., and Ghosh, C. (2021). Drug Delivery Challenges in Brain Disorders across the Blood-Brain Barrier: Novel Methods and Future Considerations for Improved Therapy. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121834"},{"key":"ref_23","unstructured":"(2023, December 20). Alzheimer\u2019s Association, Chicago, IL, 2023. Available online: https:\/\/www.alz.org\/."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s41401-020-00565-5","article-title":"New therapeutics beyond amyloid-beta and tau for the treatment of Alzheimer\u2019s disease","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mangalmurti, A., and Lukens, J.R. (2022). How neurons die in Alzheimer\u2019s disease: Implications for neuroinflammation. Curr. Opin. Neurobiol., 75.","DOI":"10.1016\/j.conb.2022.102575"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-220800","article-title":"COVID-19 as a Risk Factor for Alzheimer\u2019s Disease","volume":"91","author":"Weaver","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/1073858419848293","article-title":"Brain Injury-Mediated Neuroinflammatory Response and Alzheimer\u2019s Disease","volume":"26","author":"Kempuraj","year":"2020","journal-title":"Neuroscientist"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Alzheimer\u2019s disease","volume":"167","author":"Gonzalez","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103487","DOI":"10.1016\/j.drudis.2023.103487","article-title":"Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer\u2019s disease and related tauopathies","volume":"28","author":"Moore","year":"2023","journal-title":"Drug Discov. Today"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.25172","article-title":"High complement levels in astrocyte-derived exosomes of Alzheimer disease","volume":"83","author":"Goetzl","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"eaax3519","DOI":"10.1126\/scitranslmed.aax3519","article-title":"Chi3l1\/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer\u2019s disease pathogenesis","volume":"12","author":"Lananna","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/alz.12612","article-title":"Potential role of chitinase-3-like protein 1 (CHI3L1\/YKL-40) in neurodegeneration and Alzheimer\u2019s disease","volume":"19","author":"Connolly","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","article-title":"Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer\u2019s disease","volume":"16","author":"Elahi","year":"2020","journal-title":"Alzheimers Dement."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer\u2019s disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1073\/pnas.1812155116","article-title":"PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)","volume":"116","author":"Horti","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"fcab011","DOI":"10.1093\/braincomms\/fcab011","article-title":"Distinct microglial response against Alzheimer\u2019s amyloid and tau pathologies characterized by P2Y12 receptor","volume":"3","author":"Maeda","year":"2021","journal-title":"Brain Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nucmedbio.2022.05.001","article-title":"Radiosynthesis and initial preclinical evaluation of [(11)C]AZD1283 as a potential P2Y12R PET radiotracer","volume":"114\u2013115","author":"Jackson","year":"2022","journal-title":"Nucl. Med. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cmet.2020.02.004","article-title":"Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer\u2019s Disease","volume":"31","author":"Maugard","year":"2020","journal-title":"Cell Metab."},{"key":"ref_42","first-page":"79","article-title":"Glia Maturation Factor in the Pathogenesis of Alzheimer\u2019s disease","volume":"12","author":"Ramaswamy","year":"2019","journal-title":"Open Access J. Neurol. Neurosurg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer\u2019s Disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jagp.2019.03.002","article-title":"The Neuropsychiatry of Parkinson Disease: A Perfect Storm","volume":"27","author":"Weintraub","year":"2019","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11481-017-9766-1","article-title":"Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson\u2019s Disease","volume":"13","author":"Kempuraj","year":"2018","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_47","unstructured":"(2023, December 20). Parkinsons Foundation, Miami, FL, 2023. Available online: https:\/\/www.parkinson.org\/."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Pajares, M., Rojo, A.I., Manda, G., Bosc\u00e1, L., and Cuadrado, A. (2020). Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications. Cells, 9.","DOI":"10.3390\/cells9071687"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/brain\/awac258","article-title":"Extracellular vesicle biomarkers for cognitive impairment in Parkinson\u2019s disease","volume":"146","author":"Blommer","year":"2023","journal-title":"Brain"},{"key":"ref_50","first-page":"S3","article-title":"The Emerging Evidence of the Parkinson Pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","article-title":"Parkinson\u2019s Disease: A Multisystem Disorder","volume":"39","author":"Costa","year":"2023","journal-title":"Neurosci. Bull."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and Pathogenesis of Parkinson\u2019s Syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"105807","DOI":"10.1016\/j.parkreldis.2023.105807","article-title":"alpha-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders","volume":"117","author":"Farris","year":"2023","journal-title":"Park. Relat. Disord."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s12035-018-1177-7","article-title":"Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1\/2 MAPKs and NF-kappaB","volume":"56","author":"Kempuraj","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbi.2020.01.013","article-title":"A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice","volume":"87","author":"Selvakumar","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3389\/fneur.2019.00652","article-title":"Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications","volume":"10","author":"Limphaibool","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson\u2019s disease\u2014An evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_58","first-page":"775","article-title":"The Association Between Type 2 Diabetes Mellitus and Parkinson\u2019s Disease","volume":"10","author":"Cheong","year":"2020","journal-title":"J. Park. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e938519","DOI":"10.12659\/MSM.938519","article-title":"Autophagy and Its Association with Genetic Mutations in Parkinson Disease","volume":"28","author":"Erekat","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mds.27659","article-title":"Parkinson\u2019s disease age at onset genome-wide association study: Defining heritability, genetic loci, and alpha-synuclein mechanisms","volume":"34","author":"Blauwendraat","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_61","unstructured":"(2023, December 10). Brain Injury Association of America, Fairfax, VA. Available online: https:\/\/www.biausa.org\/."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1007\/s12035-022-02822-6","article-title":"A Literature Review of Traumatic Brain Injury Biomarkers","volume":"59","author":"Ghaith","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_63","first-page":"1003","article-title":"Neuroinflammation Induces Neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J. Neurol. Neurosurg. Spine"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s12031-021-01841-7","article-title":"Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets","volume":"71","author":"Thapa","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1179069519832286","DOI":"10.1177\/1179069519832286","article-title":"A Review of MicroRNA Biomarkers in Traumatic Brain Injury","volume":"13","author":"Atif","year":"2019","journal-title":"J. Exp. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2147\/NDT.S125620","article-title":"Biomarkers in traumatic brain injury (TBI): A review","volume":"14","author":"Dadas","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2021.05.025","article-title":"Traumatic Brain Injury and Risk of Neurodegenerative Disorder","volume":"91","author":"Brett","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Hier, D.B., Obafemi-Ajayi, T., Thimgan, M.S., Olbricht, G.R., Azizi, S., Allen, B., Hadi, B.A., and Wunsch, D.C. (2021). Blood biomarkers for mild traumatic brain injury: A selective review of unresolved issues. Biomark. Res., 9.","DOI":"10.1186\/s40364-021-00325-5"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s10143-020-01421-0","article-title":"Biomarkers for traumatic brain injury: A short review","volume":"44","author":"Gutierre","year":"2021","journal-title":"Neurosurg. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Coppens, S., Lehmann, S., Hopley, C., and Hirtz, C. (2023). Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411624"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fncel.2020.00187","article-title":"Neuroimmune System as a Driving Force for Plasticity Following CNS Injury","volume":"14","author":"Tom","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.wneu.2019.07.039","article-title":"A Review of the Molecular Mechanisms of Traumatic Brain Injury","volume":"131","author":"Ladak","year":"2019","journal-title":"World Neurosurg."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Sivandzade, F., Alqahtani, F., and Cucullo, L. (2020). Traumatic Brain Injury and Blood-Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid Condition. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082721"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/jnnp-2017-317557","article-title":"Understanding neurodegeneration after traumatic brain injury: From mechanisms to clinical trials in dementia","volume":"90","author":"Graham","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Cash, A., and Theus, M.H. (2020). Mechanisms of Blood-Brain Barrier Dysfunction in Traumatic Brain Injury. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093344"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3389\/fnins.2017.00703","article-title":"Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer\u2019s Disease Pathogenesis","volume":"11","author":"Kempuraj","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jnr.24327","article-title":"Insights into major facilitator superfamily domain-containing protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far?","volume":"98","author":"Ocak","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14737159.2018.1428089","article-title":"An update on diagnostic and prognostic biomarkers for traumatic brain injury","volume":"18","author":"Wang","year":"2018","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_79","first-page":"e17056","article-title":"Systematic Review of Serum Biomarkers in Traumatic Brain Injury","volume":"13","author":"Mozaffari","year":"2021","journal-title":"Cureus"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00068-021-01693-1","article-title":"Neurofilament light chain in patients with a concussion or head impacts: A systematic review and meta-analysis","volume":"48","author":"Karantali","year":"2022","journal-title":"Eur. J. Trauma Emerg. Surg."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/acn3.51234","article-title":"Blood neurofilament light: A critical review of its application to neurologic disease","volume":"7","author":"Barro","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e22363","DOI":"10.1097\/MD.0000000000022363","article-title":"Neurofilament light chain level in traumatic brain injury: A system review and meta-analysis","volume":"99","author":"Gao","year":"2020","journal-title":"Medicine"},{"key":"ref_83","first-page":"e31301","article-title":"The Potential Role of Neurofilament Light in Mild Traumatic Brain Injury Diagnosis: A Systematic Review","volume":"14","author":"Farragher","year":"2022","journal-title":"Cureus"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/14737159.2021.2005583","article-title":"Blood-based traumatic brain injury biomarkers\u2013Clinical utilities and regulatory pathways in the United States, Europe and Canada","volume":"21","author":"Wang","year":"2021","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e000473","DOI":"10.1136\/bmjpo-2019-000473","article-title":"Evaluating glial and neuronal blood biomarkers GFAP and UCH-L1 as gradients of brain injury in concussive, subconcussive and non-concussive trauma: A prospective cohort study","volume":"3","author":"Papa","year":"2019","journal-title":"BMJ Paediatr. Open"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s13311-023-01421-0","article-title":"Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury","volume":"20","author":"Lindblad","year":"2023","journal-title":"Neurotherapeutics"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/j.wneu.2023.05.062","article-title":"Hyperbaric Oxygen Therapy for the Management of Mild and Moderate Traumatic Brain Injury: A Single-Center Experience","volume":"176","author":"Miskin","year":"2023","journal-title":"World Neurosurg."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Bested, A.C., Rana, A.M., Hardigan, P., Niyirora, J., Cheema, A., Antony, G., Defina, P.A., and Machado, C. (2022). A case series of 39 United States Veterans with mild traumatic brain injury treated with hyperbaric oxygen therapy. Clin. Trans. Neurosci., 6.","DOI":"10.3390\/ctn6030021"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Saha, P., Skidmore, P.T., Holland, L.A., Mondal, A., Bose, D., Seth, R.K., Sullivan, K., Janulewicz, P.A., Horner, R., and Klimas, N. (2021). Andrographolide Attenuates Gut-Brain-Axis Associated Pathology in Gulf War Illness by Modulating Bacteriome-Virome Associated Inflammation and Microglia-Neuron Proinflammatory Crosstalk. Brain Sci., 11.","DOI":"10.3390\/brainsci11070905"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"107716","DOI":"10.1016\/j.pharmthera.2020.107716","article-title":"Gulf War Illness: Mechanisms Underlying Brain Dysfunction and Promising Therapeutic Strategies","volume":"220","author":"Dickey","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3389\/fpsyg.2019.02088","article-title":"Neuropsychological Findings in Gulf War Illness: A Review","volume":"10","author":"Jeffrey","year":"2019","journal-title":"Front. Psychol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1002\/cpz1.707","article-title":"Experimental Models of Gulf War Illness, a Chronic Neuropsychiatric Disorder in Veterans","volume":"3","author":"Reddy","year":"2023","journal-title":"Curr. Protoc."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1007\/s00221-017-5050-0","article-title":"Gulf War illness (GWI) as a neuroimmune disease","volume":"235","author":"Georgopoulos","year":"2017","journal-title":"Exp. Brain Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40478-022-01449-x","article-title":"Impact of gulf war toxic exposures after mild traumatic brain injury","volume":"10","author":"Ferguson","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1016\/j.csbj.2022.11.006","article-title":"A pilot reverse virtual screening study suggests toxic exposures caused long-term epigenetic changes in Gulf War Illness","volume":"20","author":"Michalovicz","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1096\/fj.201802572R","article-title":"Gastrointestinal neuroimmune disruption in a mouse model of Gulf War illness","volume":"33","author":"Hernandez","year":"2019","journal-title":"FASEB J."},{"key":"ref_97","first-page":"11","article-title":"Chemical exposures and suspected impact on Gulf War Veterans","volume":"10","author":"Elhaj","year":"2023","journal-title":"Mil. Med. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"26331055211018458","DOI":"10.1177\/26331055211018458","article-title":"Adaptive Immune Responses Associated with the Central Nervous System Pathology of Gulf War Illness","volume":"16","author":"Nkiliza","year":"2021","journal-title":"Neurosci. Insights"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbi.2020.01.020","article-title":"In-vivo imaging of neuroinflammation in veterans with Gulf War illness","volume":"87","author":"Alshelh","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbi.2019.06.040","article-title":"Neuroinflammation in Gulf War Illness is linked with HMGB1 and complement activation, which can be discerned from brain-derived extracellular vesicles in the blood","volume":"81","author":"Madhu","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-023-06319-5","article-title":"Pathophysiological basis and promise of experimental therapies for Gulf War Illness, a chronic neuropsychiatric syndrome in veterans","volume":"240","author":"Kodali","year":"2023","journal-title":"Psychopharmacology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2633105520942480","DOI":"10.1177\/2633105520942480","article-title":"Host Akkermansia muciniphila Abundance Correlates With Gulf War Illness Symptom Persistence via NLRP3-Mediated Neuroinflammation and Decreased Brain-Derived Neurotrophic Factor","volume":"15","author":"Kimono","year":"2020","journal-title":"Neurosci. Insights"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Seth, R.K., Maqsood, R., Mondal, A., Bose, D., Kimono, D., Holland, L.A., Janulewicz Lloyd, P., Klimas, N., Horner, R.D., and Sullivan, K. (2019). Gut DNA Virome Diversity and Its Association with Host Bacteria Regulate Inflammatory Phenotype and Neuronal Immunotoxicity in Experimental Gulf War Illness. Viruses, 11.","DOI":"10.3390\/v11100968"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Bose, D., Saha, P., Mondal, A., Fanelli, B., Seth, R.K., Janulewicz, P., Sullivan, K., Lasley, S., Horner, R., and Colwell, R.R. (2020). Obesity Worsens Gulf War Illness Symptom Persistence Pathology by Linking Altered Gut Microbiome Species to Long-Term Gastrointestinal, Hepatic, and Neuronal Inflammation in a Mouse Model. Nutrients, 12.","DOI":"10.3390\/nu12092764"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/jnc.13088","article-title":"Corticosterone primes the neuroinflammatory response to DFP in mice: Potential animal model of Gulf War Illness","volume":"133","author":"Kelly","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbi.2017.08.003","article-title":"Corticosterone potentiates DFP-induced neuroinflammation and affects high-order diffusion imaging in a rat model of Gulf War Illness","volume":"67","author":"Koo","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"152894","DOI":"10.1016\/j.tox.2021.152894","article-title":"Dysregulation of cellular energetics in Gulf War Illness","volume":"461","author":"Raju","year":"2021","journal-title":"Toxicology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuro.2012.01.014","article-title":"FMRI reveals abnormal central processing of sensory and pain stimuli in ill Gulf War veterans","volume":"33","author":"Gopinath","year":"2012","journal-title":"Neurotoxicology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12974-018-1113-9","article-title":"Epigenetic impacts of stress priming of the neuroinflammatory response to sarin surrogate in mice: A model of Gulf War illness","volume":"15","author":"Ashbrook","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"120153","DOI":"10.1016\/j.lfs.2021.120153","article-title":"Induction of distinct neuroinflammatory markers and gut dysbiosis by differential pyridostigmine bromide dosing in a chronic mouse model of GWI showing persistent exercise fatigue and cognitive impairment","volume":"288","author":"Kozlova","year":"2022","journal-title":"Life Sci."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Shetty, A.K., Attaluri, S., Kodali, M., Shuai, B., Shetty, G.A., Upadhya, D., Hattiangady, B., Madhu, L.N., Upadhya, R., and Bates, A. (2020). Monosodium luminol reinstates redox homeostasis, improves cognition, mood and neurogenesis, and alleviates neuro- and systemic inflammation in a model of Gulf War Illness. Redox Biol., 28.","DOI":"10.1016\/j.redox.2019.101389"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"113366","DOI":"10.1016\/j.bbr.2021.113366","article-title":"Minocycline alleviates Gulf War Illness rats via altering gut microbiome, attenuating neuroinflammation and enhancing hippocampal neurogenesis","volume":"410","author":"Liu","year":"2021","journal-title":"Behav. Brain Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbi.2018.03.017","article-title":"The potential of treating Gulf War Illness with curcumin","volume":"70","author":"Leibowitz","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbi.2018.01.009","article-title":"Curcumin treatment leads to better cognitive and mood function in a model of Gulf War Illness with enhanced neurogenesis, and alleviation of inflammation and mitochondrial dysfunction in the hippocampus","volume":"69","author":"Kodali","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_115","first-page":"31","article-title":"Progression of intervention-focused research for Gulf War illness","volume":"6","author":"Chester","year":"2019","journal-title":"Mil. Med. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"119819","DOI":"10.1016\/j.lfs.2021.119819","article-title":"A randomized phase II remote study to assess Bacopa for Gulf War Illness associated cognitive dysfunction: Design and methods of a national study","volume":"282","author":"Cheema","year":"2021","journal-title":"Life Sci."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Helmer, D.A., Van Doren, W.W., Litke, D.R., Tseng, C.L., Ho, L., Osinubi, O., and Pasinetti, G.M. (2020). Safety, Tolerability and Efficacy of Dietary Supplementation with Concord Grape Juice in Gulf War Veterans with Gulf War Illness: A Phase I\/IIA, Randomized, Double-Blind, Placebo-Controlled Trial. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17103546"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e2245272","DOI":"10.1001\/jamanetworkopen.2022.45272","article-title":"Effect of Problem-solving Treatment on Self-reported Disability Among Veterans With Gulf War Illness: A Randomized Clinical Trial","volume":"5","author":"McAndrew","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"107045","DOI":"10.1016\/j.cct.2022.107045","article-title":"Study protocol for a revised randomized trial: Remotely delivered Tai Chi and wellness for Gulf War illness","volume":"125","author":"Niles","year":"2023","journal-title":"Contemp. Clin. Trials"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Allende, S., Mathersul, D.C., Schulz-Heik, J.R., Avery, T.J., Mahoney, L., and Bayley, P.J. (2023). Yoga is effective for treating chronic pain in veterans with Gulf War Illness at long-term follow-up. BMC Complement. Med. Ther., 23.","DOI":"10.1186\/s12906-023-04145-y"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"119147","DOI":"10.1016\/j.lfs.2021.119147","article-title":"Cognitive behavioral therapy for insomnia in veterans with gulf war illness: Results from a randomized controlled trial","volume":"279","author":"Chao","year":"2021","journal-title":"Life Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/jama.289.11.1396","article-title":"Cognitive behavioral therapy and aerobic exercise for Gulf War veterans\u2019 illnesses: A randomized controlled trial","volume":"289","author":"Donta","year":"2003","journal-title":"JAMA"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Baraniuk, J.N., Kern, G., Narayan, V., and Cheema, A. (2021). Exercise modifies glutamate and other metabolic biomarkers in cerebrospinal fluid from Gulf War Illness and Myalgic encephalomyelitis \/ Chronic Fatigue Syndrome. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0244116"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12967-021-03143-3","article-title":"An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"19","author":"Wirth","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_125","unstructured":"Centers for Disease Control and Prevention (CDC) (2023). Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS), Centers for Disease Control and Prevention."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Cortes Rivera, M., Mastronardi, C., Silva-Aldana, C.T., Arcos-Burgos, M., and Lidbury, B.A. (2019). Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: A Comprehensive Review. Diagnostics, 9.","DOI":"10.3390\/diagnostics9030091"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"877772","DOI":"10.3389\/fneur.2022.877772","article-title":"Molecular Mechanisms of Neuroinflammation in ME\/CFS and Long COVID to Sustain Disease and Promote Relapses","volume":"13","author":"Tate","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Kasimir, F., Toomey, D., Liu, Z., Kaiping, A.C., Ariza, M.E., and Prusty, B.K. (2022). Tissue specific signature of HHV-6 infection in ME\/CFS. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.1044964"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2967\/jnumed.113.131045","article-title":"Neuroinflammation in Patients with Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis: An (1)(1)C-(R)-PK11195 PET Study","volume":"55","author":"Nakatomi","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"769511","DOI":"10.3389\/fneur.2021.769511","article-title":"Brainstem Abnormalities in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: A Scoping Review and Evaluation of Magnetic Resonance Imaging Findings","volume":"12","author":"Nelson","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Marks, D.F. (2023). Converging Evidence of Similar Symptomatology of ME\/CFS and PASC Indicating Multisystemic Dyshomeostasis. Biomedicines, 11.","DOI":"10.31234\/osf.io\/3xyvg"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2362.1987.tb01148.x","article-title":"Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers","volume":"17","author":"Tonnesen","year":"1987","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"701419","DOI":"10.3389\/fneur.2021.701419","article-title":"A Paradigm for Post-COVID-19 Fatigue Syndrome Analogous to ME\/CFS","volume":"12","author":"Mackay","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2021.03.023","article-title":"Skewing of the B cell receptor repertoire in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"95","author":"Sato","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e89376","DOI":"10.1172\/jci.insight.89376","article-title":"Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome","volume":"1","author":"Fluge","year":"2016","journal-title":"JCI Insight"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"100412","DOI":"10.1016\/j.bbih.2022.100412","article-title":"Circadian rhythm disruption in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Implications for the post-acute sequelae of COVID-19","volume":"20","author":"McCarthy","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.molmed.2021.06.002","article-title":"Insights from myalgic encephalomyelitis\/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome","volume":"27","author":"Komaroff","year":"2021","journal-title":"Trends Mol. Med."},{"key":"ref_138","first-page":"1","article-title":"Kindling and Oxidative Stress as Contributors to Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"7","author":"Jason","year":"2009","journal-title":"J. Behav. Neurosci. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.tim.2020.03.003","article-title":"Herpes Simplex Virus-1 in the Brain: The Dark Side of a Sneaky Infection","volume":"28","author":"Marcocci","year":"2020","journal-title":"Trends Microbiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e18250","DOI":"10.1016\/j.heliyon.2023.e18250","article-title":"Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and multiple sclerosis","volume":"9","author":"Domingues","year":"2023","journal-title":"Heliyon"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"928945","DOI":"10.3389\/fimmu.2022.928945","article-title":"Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"13","author":"Gravelsina","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome\u2014Evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Loebel, M., Eckey, M., Sotzny, F., Hahn, E., Bauer, S., Grabowski, P., Zerweck, J., Holenya, P., Hanitsch, L.G., and Wittke, K. (2017). Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179124"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/brain\/awaa394","article-title":"Modulation of beta bursts in subthalamic sensorimotor circuits predicts improvement in bradykinesia","volume":"144","author":"Kehnemouyi","year":"2021","journal-title":"Brain"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"102527","DOI":"10.1016\/j.autrev.2020.102527","article-title":"A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): Recognitions from the finding of autoantibodies against ss2-adrenergic receptors","volume":"19","author":"Wirth","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Shukla, S.K., Cook, D., Meyer, J., Vernon, S.D., Le, T., Clevidence, D., Robertson, C.E., Schrodi, S.J., Yale, S., and Frank, D.N. (2015). Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS). PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145453"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12035-013-8553-0","article-title":"The emerging role of autoimmunity in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/cfs)","volume":"49","author":"Morris","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1194754","DOI":"10.3389\/fmed.2023.1194754","article-title":"Fighting Post-COVID and ME\/CFS\u2014Development of curative therapies","volume":"10","author":"Scheibenbogen","year":"2023","journal-title":"Front. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"842991","DOI":"10.3389\/fmed.2022.842991","article-title":"Diagnosis of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles","volume":"9","author":"Xu","year":"2022","journal-title":"Front. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/s41598-023-28955-9","article-title":"Circulating microRNA expression signatures accurately discriminate myalgic encephalomyelitis from fibromyalgia and comorbid conditions","volume":"13","author":"Nepotchatykh","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Helliwell, A.M., Stockwell, P.A., Edgar, C.D., Chatterjee, A., and Tate, W.P. (2022). Dynamic Epigenetic Changes during a Relapse and Recovery Cycle in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Int. J. Mol. Sci., 23.","DOI":"10.1101\/2022.02.24.22270912"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12967-023-04179-3","article-title":"Proteomics and cytokine analyses distinguish myalgic encephalomyelitis\/chronic fatigue syndrome cases from controls","volume":"21","author":"Giloteaux","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"E7150","DOI":"10.1073\/pnas.1710519114","article-title":"Cytokine signature associated with disease severity in chronic fatigue syndrome patients","volume":"114","author":"Montoya","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mehy.2015.11.024","article-title":"The role of the hippocampus in the pathogenesis of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS)","volume":"86","author":"Saury","year":"2016","journal-title":"Med. Hypotheses"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"eabq2422","DOI":"10.1126\/sciadv.abq2422","article-title":"Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients","volume":"8","author":"Vogl","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1111\/jcmm.15260","article-title":"Unravelling myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): Gender-specific changes in the microRNA expression profiling in ME\/CFS","volume":"24","author":"Cheema","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1111\/ejn.15828","article-title":"Exosome-Associated Mitochondrial DNA from Patients with ME\/CFS Stimulates Human Cultured Microglia to Release IL-1beta","volume":"56","author":"Tsilioni","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Soffritti, I., Gravelsina, S., D\u2019Accolti, M., Bini, F., Mazziga, E., Vilmane, A., Rasa-Dzelzkaleja, S., Nora-Krukle, Z., Krumina, A., and Murovska, M. (2023). Circulating miRNAs Expression in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310582"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12967-023-04295-0","article-title":"A systematic review and meta-analysis of urinary biomarkers in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"21","author":"Taccori","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/bph.13702","article-title":"Treatment and management of chronic fatigue syndrome\/myalgic encephalomyelitis: All roads lead to Rome","volume":"174","author":"Santillo","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13063-024-07982-5","article-title":"IA-PACS-CFS: A double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)","volume":"25","author":"Machule","year":"2024","journal-title":"Trials"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12967-021-02721-9","article-title":"Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): A retrospective study of 101 patients treated with a low dose of Aripiprazole","volume":"19","author":"Crosby","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/21678421.2023.2232812","article-title":"The natural history of ALS: Baseline characteristics from a multicenter clinical cohort","volume":"24","author":"Berger","year":"2023","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e075037","DOI":"10.1136\/bmj-2023-075037","article-title":"Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis","volume":"383","author":"Ilieva","year":"2023","journal-title":"BMJ"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40035-023-00377-7","article-title":"Pathological insights from amyotrophic lateral sclerosis animal models: Comparisons, limitations, and challenges","volume":"12","author":"Zhu","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neures.2023.09.002","article-title":"Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis","volume":"197","author":"Donini","year":"2023","journal-title":"Neurosci. Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00685-6","article-title":"Fluid biomarkers for amyotrophic lateral sclerosis: A review","volume":"19","author":"Irwin","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: From genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"ref_170","first-page":"7","article-title":"Amyotrophic lateral sclerosis and environmental factors","volume":"31","author":"Bozzoni","year":"2016","journal-title":"Funct. Neurol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","article-title":"Immune dysregulation in amyotrophic lateral sclerosis: Mechanisms and emerging therapies","volume":"18","author":"Beers","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"578290","DOI":"10.1016\/j.jneuroim.2024.578290","article-title":"Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"388","author":"Wang","year":"2024","journal-title":"J. Neuroimmunol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1246768","DOI":"10.3389\/fimmu.2023.1246768","article-title":"Neutrophils: A subgroup of neglected immune cells in ALS","volume":"14","author":"Cao","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-981-19-7376-5_3","article-title":"Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases","volume":"1411","author":"Nainu","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14336\/AD.2023.0519","article-title":"The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis","volume":"15","author":"He","year":"2024","journal-title":"Aging Dis."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41582-023-00915-x","article-title":"Inflammasomes in neurological disorders\u2014Mechanisms and therapeutic potential","volume":"20","author":"Ravichandran","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"De Marchi, F., Tondo, G., Corrado, L., Menegon, F., Aprile, D., Anselmi, M., D\u2019Alfonso, S., Comi, C., and Mazzini, L. (2023). Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants. Genes, 14.","DOI":"10.3390\/genes14081658"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1193636","DOI":"10.3389\/fnmol.2023.1193636","article-title":"RNA-binding proteins as a common ground for neurodegeneration and inflammation in amyotrophic lateral sclerosis and multiple sclerosis","volume":"16","author":"Chiquete","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Carata, E., Muci, M., Di Giulio, S., Mariano, S., and Panzarini, E. (2023). Looking to the Future of the Role of Macrophages and Extracellular Vesicles in Neuroinflammation in ALS. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411251"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1223096","DOI":"10.3389\/fimmu.2023.1223096","article-title":"Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis","volume":"14","author":"Calafatti","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Yang, K., Liu, Y., and Zhang, M. (2024). The Diverse Roles of Reactive Astrocytes in the Pathogenesis of Amyotrophic Lateral Sclerosis. Brain Sci., 14.","DOI":"10.3390\/brainsci14020158"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1096\/fj.11-197194","article-title":"Microglia and mast cells: Two tracks on the road to neuroinflammation","volume":"26","author":"Skaper","year":"2012","journal-title":"FASEB J."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1159\/000443093","article-title":"Induction of Microglial Activation by Mediators Released from Mast Cells","volume":"38","author":"Zhang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/1744666X.2023.2200936","article-title":"Mast cell activation: Beyond histamine and tryptase","volume":"19","author":"Theoharides","year":"2023","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12634","article-title":"Mast cells as sources of cytokines, chemokines, and growth factors","volume":"282","author":"Mukai","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e123249","DOI":"10.1172\/jci.insight.123249","article-title":"Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS","volume":"3","author":"Trias","year":"2018","journal-title":"JCI Insight"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"17728","DOI":"10.1038\/s41598-019-53982-w","article-title":"Cromolyn sodium delays disease onset and is neuroprotective in the SOD1(G93A) Mouse Model of amyotrophic lateral sclerosis","volume":"9","author":"Granucci","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.clinthera.2020.01.010","article-title":"Amyotrophic Lateral Sclerosis, Neuroinflammation, and Cromolyn","volume":"42","author":"Theoharides","year":"2020","journal-title":"Clin. Ther."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"E7049","DOI":"10.1073\/pnas.1604992113","article-title":"Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism","volume":"113","author":"Patel","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1124\/jpet.117.240564","article-title":"Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells","volume":"361","author":"Patel","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1073\/pnas.0913572107","article-title":"A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone","volume":"107","author":"Jang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1238453","DOI":"10.3389\/fnmol.2023.1238453","article-title":"Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis","volume":"16","author":"Stansberry","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.2174\/1570159X20666220915103613","article-title":"Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis","volume":"21","author":"Meanti","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ncl.2015.07.001","article-title":"Familial Amyotrophic Lateral Sclerosis","volume":"33","author":"Boylan","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"Mackenzie","year":"2011","journal-title":"Neuron"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1126\/science.8351519","article-title":"Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase","volume":"261","author":"Deng","year":"1993","journal-title":"Science"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2015.11.049","article-title":"Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis","volume":"577","author":"Kaur","year":"2016","journal-title":"Gene"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40478-016-0340-5","article-title":"From animal models to human disease: A genetic approach for personalized medicine in ALS","volume":"4","author":"Valdmanis","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Banci, L., Bertini, I., Boca, M., Girotto, S., Martinelli, M., Valentine, J.S., and Vieru, M. (2008). SOD1 and amyotrophic lateral sclerosis: Mutations and oligomerization. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001677"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Kodavati, M., Wang, H., and Hegde, M.L. (2020). Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective. Cells, 9.","DOI":"10.3390\/cells9041065"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4103\/1673-5374.382233","article-title":"The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis","volume":"19","author":"Wang","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.neuron.2019.02.032","article-title":"Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS","volume":"101","author":"Cook","year":"2019","journal-title":"Neuron"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/hmg\/ddt528","article-title":"Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models","volume":"23","author":"Magrane","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Madruga, E., Maestro, I., and Martinez, A. (2021). Mitophagy Modulation, a New Player in the Race against ALS. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020740"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1093\/hmg\/ddx348","article-title":"Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels","volume":"26","author":"Moller","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"NS20180062","DOI":"10.1042\/NS20180062","article-title":"Mitochondrial quality control and neurodegenerative diseases","volume":"2","author":"Gao","year":"2018","journal-title":"Neuronal Signal"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1093\/hmg\/ddt319","article-title":"The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons","volume":"22","author":"Wang","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cmet.2021.01.005","article-title":"C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly","volume":"33","author":"Wang","year":"2021","journal-title":"Cell Metab."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuron.2016.09.015","article-title":"Poly(GR) in C9ORF72-Related ALS\/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons","volume":"92","author":"Lu","year":"2016","journal-title":"Neuron"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40035-015-0037-x","article-title":"Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis","volume":"4","author":"Jiang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/acn3.51887","article-title":"Therapeutic targeting of ALS pathways: Refocusing an incomplete picture","volume":"10","author":"Maragakis","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Cunha-Oliveira, T., Montezinho, L., Simoes, R.F., Carvalho, M., Ferreiro, E., and Silva, F.S.G. (2024). Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis. Cells, 13.","DOI":"10.3390\/cells13030248"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1133546","DOI":"10.3389\/fneur.2023.1133546","article-title":"Modulation of the gut-brain axis via the gut microbiota: A new era in treatment of amyotrophic lateral sclerosis","volume":"14","author":"Hong","year":"2023","journal-title":"Front. Neurol."},{"key":"ref_219","unstructured":"Van Daele, S.H., Masrori, P., Van Damme, P., and Van Den Bosch, L. (2024). The sense of antisense therapies in ALS. Trends Mol. Med., S1471-4914(23)00283-6."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.2023048372","article-title":"Personalized Precision Immunotherapy for Amyotrophic Lateral Sclerosis (ALS)","volume":"43","author":"Maharaj","year":"2023","journal-title":"Crit. Rev. Immunol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00018-022-04217-1","article-title":"Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes","volume":"79","author":"Rizzuti","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/jnc.16005","article-title":"Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis","volume":"167","author":"Okano","year":"2023","journal-title":"J. Neurochem."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"dev156166","DOI":"10.1242\/dev.156166","article-title":"Modeling human diseases with induced pluripotent stem cells: From 2D to 3D and beyond","volume":"145","author":"Liu","year":"2018","journal-title":"Development"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.stem.2020.02.011","article-title":"Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery","volume":"26","author":"Sharma","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Aboul-Soud, M.A.M., Alzahrani, A.J., and Mahmoud, A. (2021). Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening. Cells, 10.","DOI":"10.3390\/cells10092319"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1007\/s10571-023-01344-6","article-title":"The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review","volume":"43","author":"Pekala","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.stemcr.2021.11.009","article-title":"A functional hiPSC-cortical neuron differentiation and maturation model and its application to neurological disorders","volume":"17","author":"Autar","year":"2022","journal-title":"Stem Cell Rep."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12987-019-0145-6","article-title":"An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons","volume":"16","author":"Canfield","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"9636897211017829","DOI":"10.1177\/09636897211017829","article-title":"Differentiation of Human Pluripotent Stem Cells Into Specific Neural Lineages","volume":"30","author":"Chang","year":"2021","journal-title":"Cell Transplant."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4103\/1673-5374.378203","article-title":"Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons","volume":"19","author":"Chen","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/978-1-0716-2811-9_16","article-title":"Transcription Factor-Mediated Differentiation of Motor Neurons from Human Pluripotent Stem Cells","volume":"2593","author":"Wu","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Marrone, L., Bus, C., Schondorf, D., Fitzgerald, J.C., Kubler, M., Schmid, B., Reinhardt, P., Reinhardt, L., Deleidi, M., and Levin, T. (2018). Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson\u2019s disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192497"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"fcac267","DOI":"10.1093\/braincomms\/fcac267","article-title":"Neurons derived from individual early Alzheimer\u2019s disease patients reflect their clinical vulnerability","volume":"4","author":"Ng","year":"2022","journal-title":"Brain Commun."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.neuron.2023.01.010","article-title":"Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects","volume":"111","author":"Workman","year":"2023","journal-title":"Neuron"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1089\/neu.2022.0508","article-title":"Modeling the Inflammatory Response of Traumatic Brain Injury Using Human Induced Pluripotent Stem Cell Derived Microglia","volume":"40","author":"Alam","year":"2023","journal-title":"J. Neurotrauma"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1007\/s00018-021-03942-3","article-title":"A cellular approach to understanding and treating Gulf War Illness","volume":"78","author":"Yates","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.4252\/wjsc.v13.i8.1134","article-title":"Induced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"13","author":"Morten","year":"2021","journal-title":"World J. Stem Cells"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson\u2019s Disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14802\/jmd.22141","article-title":"Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson\u2019s Disease","volume":"16","author":"Cha","year":"2023","journal-title":"J. Mov. Disord."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4062\/biomolther.2022.140","article-title":"Efficient Generation of Dopaminergic Neurons from Mouse Ventral Midbrain Astrocytes","volume":"31","author":"Han","year":"2023","journal-title":"Biomol. Ther."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Wang, Y., Xia, Y., Kou, L., Yin, S., Chi, X., Li, J., Sun, Y., Wu, J., Zhou, Q., and Zou, W. (2023). Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson\u2019s disease. Neurobiol. Dis., 184.","DOI":"10.1016\/j.nbd.2023.106224"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41420-023-01531-w","article-title":"Rapid degeneration of iPSC-derived motor neurons lacking Gdap1 engages a mitochondrial-sustained innate immune response","volume":"9","author":"Leon","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cels.2020.10.010","article-title":"Cross-Comparison of Human iPSC Motor Neuron Models of Familial and Sporadic ALS Reveals Early and Convergent Transcriptomic Disease Signatures","volume":"12","author":"Ho","year":"2021","journal-title":"Cell Syst."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"979652","DOI":"10.3389\/fncel.2022.979652","article-title":"Veteran-derived cerebral organoids display multifaceted pathological defects in studies on Gulf War Illness","volume":"16","author":"Yates","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"e164637","DOI":"10.1172\/JCI164637","article-title":"iPSC-derived reactive astrocytes from patients with multiple sclerosis protect cocultured neurons in inflammatory conditions","volume":"133","author":"Kerkering","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"103533","DOI":"10.1016\/j.mcn.2020.103533","article-title":"Models of the blood-brain barrier using iPSC-derived cells","volume":"107","author":"Delsing","year":"2020","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"863836","DOI":"10.3389\/fncel.2022.863836","article-title":"Study of BBB Dysregulation in Neuropathogenicity Using Integrative Human Model of Blood-Brain Barrier","volume":"16","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/joa.13463","article-title":"Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS)","volume":"241","author":"Alhindi","year":"2022","journal-title":"J. Anat."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1038\/s41467-021-24776-4","article-title":"Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions","volume":"12","author":"Pereira","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Massih, B., Veh, A., Schenke, M., Mungwa, S., Seeger, B., Selvaraj, B.T., Chandran, S., Reinhardt, P., Sterneckert, J., and Hermann, A. (2023). A 3D cell culture system for bioengineering human neuromuscular junctions to model ALS. Front. Cell. Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.996952"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fncel.2019.00054","article-title":"Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer\u2019s Disease","volume":"13","author":"Kempuraj","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Kumar, M., Nguyen, N.T.P., Milanese, M., and Bonanno, G. (2022). Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders. Biomolecules, 12.","DOI":"10.3390\/biom12030344"},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Yeap, Y.J., Teddy, T.J.W., Lee, M.J., Goh, M., and Lim, K.L. (2023). From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson\u2019s Disease Modeling and Regenerative Therapy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032523"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1002\/cpz1.555","article-title":"Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells","volume":"2","author":"Sozzi","year":"2022","journal-title":"Curr. Protoc."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.tins.2022.05.001","article-title":"Induced pluripotent stem cells: A tool for modeling Parkinson\u2019s disease","volume":"45","author":"Bose","year":"2022","journal-title":"Trends Neurosci."},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Yefroyev, D.A., and Jin, S. (2022). Induced Pluripotent Stem Cells for Treatment of Alzheimer\u2019s and Parkinson\u2019s Diseases. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020208"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/mds.28810","article-title":"Parkinson\u2019s Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-beta-Cyclodextrin Treatment","volume":"37","author":"Jarazo","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13365-023-01133-3","article-title":"iPSC-derived three-dimensional brain organoid models and neurotropic viral infections","volume":"29","author":"Swingler","year":"2023","journal-title":"J. Neurovirol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.stem.2020.09.016","article-title":"Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium","volume":"27","author":"Jacob","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Sahlgren Bendtsen, K.M., and Hall, V.J. (2023). The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer\u2019s Disease. Cells, 12.","DOI":"10.3390\/cells12030420"},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Pandey, S., Jirasko, M., Lochman, J., Chvatal, A., Chottova Dvorakova, M., and Kucera, R. (2022). iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine. J. Pers. Med., 12.","DOI":"10.3390\/jpm12091485"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/nyas.14012","article-title":"Human pluripotent stem cell-derived models and drug screening in CNS precision medicine","volume":"1471","author":"Silva","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Kim, S.H., and Chang, M.Y. (2023). Application of Human Brain Organoids-Opportunities and Challenges in Modeling Human Brain Development and Neurodevelopmental Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512528"},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Parsaeimehr, A., Ebirim, R.I., and Ozbay, G. (2022). CRISPR-Cas technology a new era in genomic engineering. Biotechnol. Rep., 34.","DOI":"10.1016\/j.btre.2022.e00731"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/6\/511\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:13:43Z","timestamp":1760105623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/6\/511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":264,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["cells13060511"],"URL":"https:\/\/doi.org\/10.3390\/cells13060511","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}